DRMTY OTC
Dr. Martens plc
1W: +2.8%
1M: -13.9%
3M: -4.2%
YTD: -5.6%
1Y: -28.9%
3Y: -41.5%
$1.85
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$765M
-2.9% ▼
5Y CAGR: -0.2%
Gross Profit
$506M
-1.1% ▼
5Y CAGR: +1.5%
Operating Income
$140M
+149.7% ▲
5Y CAGR: +4.5%
Net Income
$24M
+428.9% ▲
5Y CAGR: -7.3%
EPS (Diluted)
$0.05
+384.0% ▲
5Y CAGR: -7.0%
EBITDA
$128M
+15.6% ▲
5Y CAGR: -2.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $908M | $1.0B | $877M | $788M | $765M |
| YoY Growth | +17.5% | +10.1% | -12.3% | -10.2% | -2.9% |
| Cost of Revenue | $330M | $382M | $302M | $276M | $259M |
| Gross Profit | $579M | $618M | $575M | $512M | $506M |
| Gross Margin | 63.7% | 61.8% | 65.6% | 65.0% | 66.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $309M | $373M | $449M | $100K | -$700K |
| Operating Expenses | $353M | $427M | $449M | $456M | $446M |
| Operating Income | $228M | $181M | $126M | $56M | $140M |
| Operating Margin | 25.1% | 18.1% | 14.4% | 7.1% | 18.3% |
| Interest Expense | $14M | $18M | $31M | $29M | $28M |
| Income Before Tax | $214M | $159M | $93M | $9M | $33M |
| Tax Expense | $33M | $30M | $24M | $4M | $9M |
| Net Income | $181M | $129M | $69M | $4M | $24M |
| Net Margin | 19.9% | 12.9% | 7.9% | 0.6% | 3.1% |
| EPS (Diluted) | $0.36 | $0.26 | $0.14 | $0.01 | $0.05 |
| EBITDA | $265M | $235M | $196M | $110M | $128M |
| Shares Outstanding | 501M | 501M | 493M | 487M | 490M |